Alliance Oklahoma Home Health North Central Location: 111 Patton Drive, Suite 2, Ponca City, Oklahoma 74601 Ratings: Phone: (580) 765-8155 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Healthback Home Health Of Ponca City Location: 111 Patton Drive, Suite A, Ponca City, Oklahoma 74601 Ratings: Phone: (405) 842-1700 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Home Health Aide |
Advanced Homecare Location: 1113 E Hartford, Ponca City, Oklahoma 74601 Ratings:NA Phone: (580) 765-9241 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology |
Precise Home Health Care Location: 900 East Hartford, Ponca City, Oklahoma 74601 Ratings: Phone: (580) 762-6000 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
Scientists at Oregon Research Institute have published unique research results indicating that a brief dissonance-based eating disorder prevention program (Body Project) alters how young women's brains respond to images of thin supermodels.
There are few dishes that bring out as much pride and passion from Canadians as chili. With football season and plunging temperatures in full swing, there is no better time for chili enthusiasts to get back into the kitchen, perfect their chili recipes and put them to the ultimate test in the second annual ZANTAC(R) Chili Challenge.
A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants. This is the finding of a research collaboration involving Adrian Krainer, Ph.D., of Cold Spring Harbor Laboratory (CSHL) and scientists from Paratek Pharmaceuticals and Rosalind Franklin University of Medicine and Science.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, announced today the grant of US Patent 7,682,783 and US Patent 7,682,784 entitled "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics". The USPTO awarded the patents to Metabolon on March 23, 2010. The issued claims in the new patents are for uses of metabolomics to identify diagnostic biomarkers for depression and schizophrenia by profiling classes of metabolites in a sample.
› Verified 4 days ago